Credible risk or calculated chaos? You decide...
Intro: A Pandemic Sequel in the Making?
As the Biden administration quietly extends pandemic-era protections for COVID vaccine manufacturers, many Americans are left scratching their heads. The justification given—a "credible risk" of another pandemic spiraling out of control in the next four years—seems strangely out of sync with the current reality. With COVID deaths and hospitalizations at record lows, one has to wonder: What does the administration know that the public does not? Or, more unsettlingly, is this the first act in a carefully orchestrated sequel to the COVID-19 pandemic—a Plandemic Part II?
This question becomes even more pressing in light of a recent story that flew onto the radar: The CDC has revealed that a case of the Bird Flu virus in Louisiana may have mutated, potentially making it easier to infect humans. Are these two developments mere coincidences, or do they fit together as pieces of a larger, more ominous puzzle?
The "Credible Risk" Shield: A Setup for Round Two?
The Biden administration’s decision to protect pharmaceutical companies from lawsuits for the next four years under the guise of a "credible risk" raises red flags. The term “credible risk” is no throwaway phrase; it implies a tangible and plausible threat backed by data or expert analysis. Yet the administration has failed to specify what this risk is. Is it a resurgence of COVID, or are we being primed for a new viral villain? Enter the Bird Flu.
Recent news about a potential mutation in the Bird Flu virus, discovered in a Louisiana patient, is eerily convenient. The CDC warns that these mutations may allow the virus to bind more effectively to receptors in human upper airways, increasing its ability to spread among people. This sounds strikingly similar to the early warnings about COVID-19. How fortuitous for the pharmaceutical industry to already have a liability waiver in place—ready to churn out vaccines without fear of lawsuits, should Bird Flu suddenly become the next global crisis.
Déjà Vu: Lessons Unlearned from COVID
For those who lived through the COVID era, this script feels all too familiar. The initial downplaying of risks, the gradual ramp-up of warnings, the sudden emergency declarations, and the endless push for vaccines—all accompanied by ever-expanding powers for governments and pharmaceutical companies. Yet, astonishingly, so many people seem ready to trust the narrative again, as though COVID never revealed the cracks in the system.
Let us not forget Dr. Anthony Fauci’s ominous statement in January 2017, when he declared, with eerie certainty, that there “will be a surprise outbreak” during the Trump administration. Not “might be,” not “could be”—but will be. The prophetic nature of this statement should have raised eyebrows, especially considering how events unfolded just a few years later. And now, with the Biden administration invoking a vague "credible risk" and Bird Flu mutations making headlines, it’s hard not to feel a sense of déjà vu.
Connecting the Dots: Coincidence or Coordination?
The timing of these developments is suspicious, to say the least. Why extend liability protections for vaccine makers now, when COVID is a waning threat? Why invoke the language of "credible risk" without offering specifics? And why, just weeks later, does the CDC announce a potentially human-adapted Bird Flu strain?
If this is purely coincidental, it’s a stunning alignment of events. But for those who lived through the COVID-19 pandemic—or Scamdemic, as some call it—this looks more like a carefully laid plan. The pieces are falling into place: a new virus, a preemptive legal shield for Big Pharma, and a population conditioned to accept emergency measures without question. The pattern is too familiar to ignore.
The Stakes of a "Credible Risk"
It’s worth breaking down what "credible risk" actually means in this context. By definition, it’s not a mere hypothetical. A credible risk is backed by evidence and considered likely to cause significant consequences. Yet, if we are to believe the administration, this risk cannot be named. Is it truly credible, then? Or is it a convenient smokescreen for further government overreach and corporate profit?
Moreover, the credibility of this risk depends on transparency, something that has been notably absent. If the Bird Flu is the "credible risk," why wasn’t the public informed earlier? And if it’s not, then what is the Biden administration preparing for? The lack of clarity only fuels suspicion and erodes trust.
Conclusion: Smelling Something Foul
As the pieces of this puzzle come together, it’s hard not to notice the stench of something foul—pun absolutely intended. The Biden administration’s vague warnings of a "credible risk," combined with the conveniently timed Bird Flu headlines, feel less like a warning and more like a setup. If we’re heading into Plandemic Part II, it’s crucial that we question the narrative now, before the wheels are fully in motion.
The public deserves answers. What exactly is this credible risk? Why extend liability protections for pharmaceutical companies when there’s no immediate threat? And why is the Bird Flu suddenly a topic of concern? Until these questions are addressed, skepticism is not only reasonable but necessary.
We’ve seen this movie before, and the ending wasn’t happy for most of us. Let’s not let history repeat itself without demanding full transparency and accountability. If there’s one thing we learned from COVID, it’s this: blind trust in those pulling the strings can have devastating consequences. Stay vigilant, stay informed, and, most importantly, stay skeptical.
Comments